Should cerebral microbleeds on magnetic resonance imaging contraindicate thrombolysis in patients with ischaemic stroke?. A systematic review of the evidence

Radiography

Volumn 17, Issue 3, 2011, Pages 254-259

  Smith, Kate ^a,b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SALFORD   (United Kingdom)

Author keywords

Cerebral microbleeds; Magnetic resonance imaging; Stroke; Thrombolysis

Indexed keywords

BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STROKE; SYSTEMATIC REVIEW;

EID: 79959579745     PISSN: 10788174     EISSN: 15322831     Source Type: Journal    
DOI: 10.1016/j.radi.2011.04.003     Document Type: Review

References (49)

1. National stroke strategy 2007, Department of Health.
2. Reducing brain damage: faster access to better stroke care National Audit Office, (03/05/2009). http://www.nao.org.uk/publications/nao_reports/05%E2%80%9306/0506452.pdf.
3. Book D. Alterations in brain function. Essentials of pathophysiology 2004, Lippincott Williams & Wilkins. C. Porth (Ed.).
4. Gunderman R.B. Essential radiology 2006, Thieme.
5. Kohrmann M., Juttler E., Fiebach J.B., et al. MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study. Lancet Neurol 2006, 5:661-667. England.
6. Fiebach J.B., Schellinger P.D., Gass A., et al. Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke Feb 2004, 35(2):502-506.
7. Fink J.N., Caplan L.R. The importance of specific diagnosis in stroke patient management. Magnetic resonance imaging in stroke 2003, Cambridge University Press. S. Davis, M. Fisher, S. Warach (Eds.).
8. Chalela J.A., Kidwell C.S., Nentwich L.M., et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet Jan 27 2007, 369(9558):293-298.
9. Larrue V., von Kummer R.R., Muller A., Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke Feb 2001, 32(2):438-441.
10. Derex L., Nighoghossian N. Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update. J Neurol Neurosurg Psychiatr Oct 2008, 79(10):1093-1099.
11. Kidwell C.S., Wintermark M. Imaging of intracranial haemorrhage. Lancet Neurol Mar 2008, 7(3):256-267.
12. Greenberg S.M., Vernooij M.W., Cordonnier C., et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol Feb 2009, 8(2):165-174.
13. Werring D. Cerebral microbleeds in stroke. Adv Clinical Neuroscience Rehabilitation 2007, 7(1):6-8.
14. Fazekas F., Kleinert R., Roob G., et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol Apr 1999, 20(4):637-642.
15. Cordonnier C., Al-Shahi Salman R., Wardlaw J. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain 2007, 130:1988-2003. England.
16. Lee S.H., Bae H.J., Yoon B.W., Kim H., Kim D.E., Roh J.K. Low concentration of serum total cholesterol is associated with multifocal signal loss lesions on gradient-echo magnetic resonance imaging: analysis of risk factors for multifocal signal loss lesions. Stroke Dec 2002, 33(12):2845-2849.
17. Cordonnier C., Potter G.M., Jackson C.A., et al. improving interrater agreement about brain microbleeds: development of the Brain Observer MicroBleed Scale (BOMBS). Stroke Jan 2009, 40(1):94-99.
18. Gregoire S.M., Chaudhary U.J., Brown M.M., et al. The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology Nov 24 2009, 73(21):1759-1766.
19. Soo Y.O., Yang S.R., Lam W.W., et al. Risk vs benefit of anti-thrombotic therapy in ischaemic stroke patients with cerebral microbleeds. J Neurol Nov 2008, 255(11):1679-1686.
20. Hjort N., Butcher K., Davis S.M., et al. Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct. Stroke Feb 2005, 36(2):388-397.
21. Sackett S., Richardson W.S., Rosenberg W., Haynes R.B. Evidence-based medicine 1998, Churchill Livingstone.
22. Glasziou P., Irwig L., Bain C., Colditz G. Systematic reviews in healthcare 2003, Cambridge University Press.
23. Khan K.S., Kunz R., Kleijnen J., Antes G. Systematic reviews to support evidence-based medicine 2003, The Royal Society of Medicine Press.
24. Kidwell C.S., Saver J.L., Villablanca J.P., et al. Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke Jan 2002, 33(1):95-98.
25. Nighoghossian N., Hermier M., Adeleine P., et al. Old microbleeds are a potential risk factor for cerebral bleeding after ischemic stroke: a gradient-echo T2*-weighted brain MRI study. Stroke Mar 2002, 33(3):735-742.
26. Switzer J.A., Hess D.C., Nichols F.T., Adams R.J. Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol Jun 2006, 5(6):501-512.
27. Caldwell D.M., Gibb D.M., Ades A.E. Validity of indirect comparisons in meta-analysis. Lancet Jan 27 2007, 369(9558):270. author reply 271.
28. Egger M., Smith G.D., Phillips A.N. Meta-analysis: principles and procedures. BMJ Dec 6 1997, 315(7121):1533-1537.
29. Evaluation tool for quantitative research studies 2005, Health Care Practice Research Development Unit, [accessed 29.04.08.]. http://www.fhsc.salford.ac.uk/hcprdu/quantitative.htm.
30. National Patient Safety Agency. Standard Operating Procedures for Research Ethics Committees. [accessed 03.05.09.]. http://www.nres.npsa.nhs.uk/news-and-publications/publications/standard-operating-procedures/.
31. Derex L., Nighoghossian N., Hermier M., et al. Thrombolysis for ischemic stroke in patients with old microbleeds on pretreatment MRI. Cerebrovasc Dis 2004, 17(2-3):238-241.
32. Kakuda W., Thijs V.N., Lansberg M.G., et al. Clinical importance of microbleeds in patients receiving IV thrombolysis. Neurology Oct 25 2005, 65(8):1175-1178.
33. Kim H.S., Lee D.H., Ryu C.W., et al. Multiple cerebral microbleeds in hyperacute ischemic stroke: impact on prevalence and severity of early hemorrhagic transformation after thrombolytic treatment. AJR Am J Roentgenol May 2006, 186(5):1443-1449.
34. Fiehler J., Albers G.W., Boulanger J.M., et al. Bleeding risk analysis in stroke imaging before thromboLysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 p.tients. Stroke Oct 2007, 38(10):2738-2744.
35. Fiehler J., Siemonsen S., Thomalla G., Illies T., Kucinski T. Combination of T2*W and FLAIR abnormalities for the prediction of parenchymal hematoma following thrombolytic therapy in 100 stroke patients. J Neuroimaging Oct 2009, 19(4):311-316.
36. Coutts S., Frayne R., Sevick R., Demchuk A. Microbleeding on MRI as a marker for hemorrhage after stroke thrombolysis. Stroke Jun 2002, 33(6):1457-1458.
37. Chalela J.A., Kang D.W., Warach S. Multiple cerebral microbleeds: MRI marker of a diffuse hemorrhage-prone state. J Neuroimaging Jan 2004, 14(1):54-57.
38. Kang D.W., Chalela J.A., Dunn W., Warach S. MRI screening before standard tissue plasminogen activator therapy is feasible and safe. Stroke Sep 2005, 36(9):1939-1943.
39. Annual meeting abstracts. J Neuroimaging 2007, 17(1):89-104. American Society of Neuroimaging 2007.
40. Glasziou P., Vandenbroucke J.P., Chalmers I. Assessing the quality of research. BMJ 2004, 328:39-41. England.
41. Tarling M., Crofts L. The essential researcher's handbook 2002, Baillière Tindall, Edinburgh.
42. Sander S., White C.M., Coleman C.I. Comparative safety and efficacy of urokinase and recombinant tissue plasminogen activator for peripheral arterial occlusion: a meta-analysis. Pharmacotherapy Jan 2006, 26(1):51-60.
43. Singer O.C., Berkefeld J., Lorenz M.W., et al. Risk of symptomatic intracerebral hemorrhage in patients treated with intra-arterial thrombolysis. Cerebrovasc Dis 2009, 27(4):368-374.
44. Vernooij M.W., van der Lugt A., Breteler M.M. Risk of thrombolysis-related hemorrhage associated with microbleed presence. Stroke Jul 2008, 39(7):e115. author reply e116.
45. Lee S.H., Kim B.J., Roh J.K. Silent microbleeds are associated with volume of primary intracerebral hemorrhage. Neurology Feb 14 2006, 66(3):430-432.
46. Berger C., Fiorelli M., Steiner T. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic?. Stroke 2002, 33(6):1330-1335.
47. NIH stroke scale National Institute of Neurological Disorders and Stroke, 08/04/2009. http://www.ninds.nih.gov/doctors/NIH_Stroke_Scale.pdf.
48. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke Nov 1997, 28(11):2109-2118. The NINDS t-PA Stroke Study Group.
49. Sibbald B., Roland M. Understanding controlled trials. Why are randomised controlled trials important?. BMJ Jan 17 1998, 316(7126):201.